Insights

These were the worst performing ASX 200 shares last week

These ASX 200 shares were in the red last week…
The post These were the worst performing ASX 200 shares last week appeared first on The Motley Fool Australia. –

A disappointing finish to the week led to the S&P/ASX 200 Index (ASX: XJO) recording a 0.8% decline to 7,393.9 points last week.

While a number of shares dropped with the market, some fell more than most. Here’s why these were the worst performing ASX 200 shares last week:

Pro Medicus Limited (ASX: PME)

The Pro Medicus share price was the worst performer on the ASX 200 last week with a 13.9% decline. This was despite the team at Morgans upgrading the health imaging company’s shares to a hold rating just days after downgrading them to a reduce rating. The broker has a price target of $54.49. The Pro Medicus share price ended the week at $46.59.

ARB Corporation Limited (ASX: ARB)

The ARB share price was out of form last week and sank 13.7% over the five days. This 4×4 parts company’s shares came under pressure after being downgraded by analysts at Credit Suisse. According to the note, Credit Suisse has downgraded its rating to underperform with a price target of $38.00. While the broker is forecasting a strong result in February, it expects margin pressures and slower growth thereafter.

Pendal Group Ltd (ASX: PDL)

The Pendal share price was a poor performer and crashed 12.7% last week. All of this decline occurred on Friday following the release of a disappointing quarterly update. That update revealed that Pendal experienced net fund outflows of $6.8 billion during the first quarter of FY 2022. This led to its funds under management (FUM) falling 2.5% to $135.7 billion during the December quarter despite the benefits of favourable market movements.

Reece Ltd (ASX: REH)

The Reece share price wasn’t far behind with an 11.2% decline. This was despite there being no news out of the plumbing parts company. Though, it is worth noting that Reece’s shares hit a record high in the previous week. This could have led to some profit taking from investors last week.

The post These were the worst performing ASX 200 shares last week appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of January 12th 2022

More reading

These were the best performing ASX 200 shares last week

Here are the top 10 ASX shares today

Pendal (ASX:PDL) share price ends disastrous day of trade down 16%

Why this expert sees an opportunity for ASX property shares in 2022

Here are the 3 most heavily traded ASX 200 shares this Friday

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended Pro Medicus Ltd. The Motley Fool Australia owns and has recommended Pro Medicus Ltd. The Motley Fool Australia has recommended ARB Corporation Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!